These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31090264)

  • 41. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The transcriptional mediator subunit MED1/TRAP220 in stromal cells is involved in hematopoietic stem/progenitor cell support through osteopontin expression.
    Sumitomo A; Ishino R; Urahama N; Inoue K; Yonezawa K; Hasegawa N; Horie O; Matsuoka H; Kondo T; Roeder RG; Ito M
    Mol Cell Biol; 2010 Oct; 30(20):4818-27. PubMed ID: 20713445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylated MED1 links transcription recycling and cancer growth.
    Chen Z; Ye Z; Soccio RE; Nakadai T; Hankey W; Zhao Y; Huang F; Yuan F; Wang H; Cui Z; Sunkel B; Wu D; Dzeng RK; Thomas-Ahner JM; Huang THM; Clinton SK; Huang J; Lazar MA; Jin VX; Roeder RG; Wang Q
    Nucleic Acids Res; 2022 May; 50(8):4450-4463. PubMed ID: 35394046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Fu X; Jeselsohn R; Pereira R; Hollingsworth EF; Creighton CJ; Li F; Shea M; Nardone A; De Angelis C; Heiser LM; Anur P; Wang N; Grasso CS; Spellman PT; Griffith OL; Tsimelzon A; Gutierrez C; Huang S; Edwards DP; Trivedi MV; Rimawi MF; Lopez-Terrada D; Hilsenbeck SG; Gray JW; Brown M; Osborne CK; Schiff R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6600-E6609. PubMed ID: 27791031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer.
    Jeong Y; Bae SY; You D; Jung SP; Choi HJ; Kim I; Lee SK; Yu J; Kim SW; Lee JE; Kim S; Nam SJ
    Cell Physiol Biochem; 2019; 53(5):805-819. PubMed ID: 31670920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.
    McDermott MS; Chumanevich AA; Lim CU; Liang J; Chen M; Altilia S; Oliver D; Rae JM; Shtutman M; Kiaris H; Győrffy B; Roninson IB; Broude EV
    Oncotarget; 2017 Feb; 8(8):12558-12575. PubMed ID: 28147342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling.
    Belakavadi M; Pandey PK; Vijayvargia R; Fondell JD
    Mol Cell Biol; 2008 Jun; 28(12):3932-42. PubMed ID: 18391015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.
    Jia Y; Chang HC; Schipma MJ; Liu J; Shete V; Liu N; Sato T; Thorp EB; Barger PM; Zhu YJ; Viswakarma N; Kanwar YS; Ardehali H; Thimmapaya B; Reddy JK
    PLoS One; 2016; 11(8):e0160755. PubMed ID: 27548259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
    Vijayvargia R; May MS; Fondell JD
    Cancer Res; 2007 May; 67(9):4034-41. PubMed ID: 17483314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation.
    Pandey PK; Udayakumar TS; Lin X; Sharma D; Shapiro PS; Fondell JD
    Mol Cell Biol; 2005 Dec; 25(24):10695-710. PubMed ID: 16314496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor.
    Chen W; Rogatsky I; Garabedian MJ
    Mol Endocrinol; 2006 Mar; 20(3):560-72. PubMed ID: 16239257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
    Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    Cuesta R; Berman AY; Alayev A; Holz MK
    J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31.
    Jiang C; Chen H; Shao L; Wang Q
    Oncol Rep; 2014 Sep; 32(3):1249-56. PubMed ID: 24969180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
    Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.